Anti-Elastase-1 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal raised against the amino-terminal region of human Elastase-1; validated for Western blot on human samples.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential
UniProt
P08217
Size
100ug
Cat. #
RP2Elastase1

In stock

SKU
RP-Elastase1

Options

As low as: $130.00

Target Overview

Elastase-1 refers to chymotrypsin-like elastase family members (CELA1 and the closely related CELA2A, UniProt P08217; EC 3.4.21.71), serine proteases of the chymotrypsin/S1 peptidase family. CELA2A is a 269-residue zymogen secreted into plasma and pancreatic juice following activation by trypsin. Substrate preference is for small hydrophobic residues, with documented activity against elastin and several plasma proteins. Beyond classical elastinolytic activity, CELA2A circulates in plasma and has been reported to modulate insulin signaling: it triggers both insulin secretion and degradation, increases insulin sensitivity, and reduces platelet hyperactivation, suggesting a role in glucose homeostasis and cardiovascular biology. CELA1 is the related pancreatic-type elastase; its tissue expression in adult humans is restricted, and its physiologic substrate spectrum has been a matter of ongoing investigation. The principal endogenous inhibitor for both enzymes in plasma and lung interstitium is α1-antitrypsin (SERPINA1), and loss of this inhibitory tone is mechanistically linked to elastin degradation in lung parenchyma. Triple Point Biologics offers three rabbit polyclonal antibodies (RP1Elastase1, RP2Elastase1, RP3Elastase1) raised against the amino-terminal region, validated on human samples by Western blot. Cross-reactivity with non-human species is predicted based on sequence conservation but has not been formally validated in-house. Researchers studying pancreatic exocrine function, neutrophil and pancreatic elastase biology, emphysema models, α1-antitrypsin deficiency, or the proposed metabolic roles of circulating CELA2A may find these reagents suitable for detecting endogenous and recombinant Elastase-1.

Background

The chymotrypsin-like elastases (CELA1, CELA2A, CELA2B, CELA3A, CELA3B) are produced as inactive zymogens, activated by trypsin in the duodenum, and contribute to dietary protein digestion. CELA2A is also detectable in plasma, where it has been implicated in non-digestive functions including modulation of insulin secretion, insulin degradation, and platelet reactivity. The reported insulin-sensitizing activity of circulating CELA2A has prompted interest in this enzyme as a candidate node in glucose metabolism, though the in vivo significance remains under study. Disease relevance centers on lung and pancreatic pathology. In α1-antitrypsin (AAT) deficiency, unopposed elastase activity contributes to alveolar wall destruction and emphysema. CELA1 has been specifically implicated in this process: Devine et al. (2025) reported that the KF4 anti-CELA1 monoclonal antibody and purified α1-antitrypsin showed similar, but not additive, efficacy in preventing emphysema in a murine AAT-deficiency model, supporting CELA1 as a relevant elastinolytic effector in lung parenchyma (PMID 39636054). Biochemical characterization by Jamwal et al. (2026) further demonstrated that human CELA1 possesses pancreatic elastase-like activity (PMID 41520764), refining earlier assumptions about its substrate preference and tissue distribution. In the pancreas, dysregulated activation of elastases contributes to acinar injury during acute pancreatitis, and elastase measurements (typically CELA1) in stool are used in the assessment of exocrine pancreatic insufficiency in research settings. The three TPB rabbit polyclonals (RP1Elastase1, RP2Elastase1, RP3Elastase1) target the amino-terminal end and have been used to detect Elastase-1 in human pancreatic tissue sections and lysates. For investigators distinguishing CELA1 from CELA2A or CELA3 family members, validation against recombinant standards is recommended, given the sequence similarity across the family.

References

  1. Jamwal D et al (2026) Human CELA1 has pancreatic elastase-like activity. Biochimie. PubMed · DOI
  2. Devine AJ et al (2025) KF4 Anti-Chymotrypsin-like Elastase 1 Antibody and Purified Alpha-1 Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine Alpha-1 Antitrypsin Deficiency. Chronic Obstr Pulm Dis. PubMed · DOI
  3. Devine AJ et al (2024) KF4 anti-CELA1 Antibody and Purified α1-Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine α1-Antitrypsin Deficiency. bioRxiv. PubMed · DOI

Additional Specifications

Gene Symbol CELA1
UniProt ID P08217
Host Species Rabbit
Species Reactivity Validated- Human
Potential
Pack Size 100ug
Immunogen (Aminoterminal end)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 29-79.
Immunogen (Catalytic domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 29-269.
Immunogen (Carboxyterminal end)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 219-269.
Alternate Names CELA1, CELA2A, Chymotrypsin-like elastase family member 1, Chymotrypsin-like elastase family member 2A, Elastase-1, Elastase-2A, Pancreatic elastase 1, EC 3.4.21.71

Frequently Asked Questions

What molecular weight band should I expect for Elastase-1 on Western blot?

CELA2A, the predominant circulating elastase-1 isoform, migrates at approximately 28–30 kDa as the mature enzyme after signal-peptide cleavage. You may also detect the 269-residue zymogen near 29 kDa in pancreatic or plasma samples, since activation by trypsin is tissue-dependent. CELA1 is closely related and runs at a similar size. If you see higher bands around 55–60 kDa, consider dimer formation under non-reducing conditions or incomplete denaturation. Always include a reducing agent and confirm your sample source, since pancreatic tissue expresses both isoforms while plasma predominantly contains CELA2A.

Does this antibody distinguish between CELA1 and CELA2A isoforms?

Most polyclonal elastase-1 antibodies raised against full-length or large fragments recognize epitopes conserved across the chymotrypsin-like elastase family, so they typically detect both CELA1 and CELA2A. The two proteins share high sequence homology within the catalytic domain. If isoform specificity is critical for your experiment, confirm by running recombinant CELA1 and CELA2A standards in parallel lanes, or consider knockdown controls in cell lines expressing one isoform preferentially. Alternatively, check whether the immunogen sequence overlaps unique N- or C-terminal regions, though this information is not always disclosed for polyclonal sera.

What is the recommended starting dilution for Western blot with this Elastase-1 antibody?

Start at 1:1000 in blocking buffer for Western blot, as indicated in the validation data. This dilution works well for lysates from pancreatic tissue or cell lines expressing moderate to high elastase-1 levels. For plasma samples or low-abundance systems, you may need to concentrate your sample or test 1:500. Always include a positive control such as human pancreatic lysate or recombinant CELA2A. If background is high, increase the dilution to 1:2000 and extend blocking time. Titrate against your specific sample type and detection system, since chemiluminescence sensitivity varies across substrates and cameras.

Which species does this Elastase-1 antibody cross-react with besides human?

This antibody is validated for human Elastase-1. Cross-reactivity with mouse, rat, or other mammalian orthologs is not confirmed and should be considered predicted at best. Elastase-1 sequences show moderate conservation across mammals, but divergence in surface loops can abolish polyclonal recognition. If you plan to work with non-human samples, run a pilot blot with lysate from the target species alongside human pancreatic control. Lack of signal does not always mean the ortholog is absent; it may reflect epitope variability. For rodent studies, consider sourcing an antibody explicitly validated in mouse or rat, particularly for IHC or IF applications.

What sample preparation steps are important for detecting Elastase-1 in plasma versus tissue lysates?

For plasma, CELA2A circulates as an active protease, so add protease inhibitors immediately upon collection and keep samples on ice. EDTA or citrate plasma works well; avoid heparin if downstream assays are sensitive to it. For pancreatic tissue, homogenize in lysis buffer containing serine-protease inhibitors such as AEBSF or PMSF, since elastase autoactivation and cross-activation by trypsin can degrade targets during extraction. Clarify lysates by centrifugation at 12,000–16,000 × g and quantify protein with a compatible assay. Elastase-1 is reasonably stable at –80 °C but loses activity through freeze-thaw cycles, so aliquot samples for single use.

What positive and negative controls should I use when validating Elastase-1 detection?

Human pancreatic tissue lysate or juice is the standard positive control, since both CELA1 and CELA2A are abundantly expressed there. Recombinant CELA2A protein serves as a defined-MW standard. For plasma studies, pooled human plasma typically shows a detectable signal. Negative controls include lysates from tissues with negligible elastase expression, such as liver or skeletal muscle, and elastase-knockout cell lines if available. Peptide-competition blocking with the immunogen peptide (if provided) confirms specificity. For IHC, normal pancreas is positive; spleen or lymph node are usually negative, helping distinguish specific signal from non-specific background in your staining protocol.

How should I store this polyclonal Elastase-1 antibody to maintain activity?

Store the antibody at –20 °C as supplied. For frequent use, aliquot into single-use volumes to avoid repeated freeze-thaw cycles, which can aggregate IgG and reduce titer. A working aliquot may be kept at 4 °C for up to one month if sodium azide or another preservative is present; check the datasheet. Do not store diluted antibody in blocking buffer for more than a few days, as carrier proteins like BSA or milk can promote microbial growth. If you observe increased background or loss of signal over time, thaw a fresh aliquot and re-titrate. Rabbit polyclonal sera remain stable for years under these conditions.

Can I use this antibody for immunohistochemistry or immunofluorescence on pancreatic sections?

Yes, Triple Point Biologics antibodies are validated for Western blot; IHC and immunofluorescence validation is in progress. For pancreatic sections, antigen retrieval is typically required: citrate buffer (pH 6.0) heat-induced epitope retrieval works well for most serine proteases. Block endogenous peroxidase if using HRP detection, and apply the primary antibody at a starting dilution around 1:100 to 1:200 overnight at 4 °C. Elastase-1 localizes to zymogen granules in acinar cells, so expect cytoplasmic punctate staining. Optimize retrieval and dilution on serial sections, and include a no-primary-antibody control to assess non-specific secondary binding.

Validation imagery coming soon

Western blot validation figures for RP-Elastase1 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

Also known as:

  • CELA1
  • CELA2A
  • Chymotrypsin-like elastase family member 1
  • Chymotrypsin-like elastase family member 2A
  • Elastase-1
  • Elastase-2A
  • Pancreatic elastase 1
  • EC 3.4.21.71
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →